Risk factors for gastrointestinal bleeding in patients with gastrointestinal cancer using edoxaban

BACKGROUND: In the Hokusai VTE Cancer study, the risk of major bleeding was 2.9% higher in the edoxaban group compared with the dalteparin group, mainly due to more gastrointestinal bleedings in patients with gastrointestinal cancer. The identification of risk factors for gastrointestinal bleeding m...

Descripción completa

Detalles Bibliográficos
Autores principales: Bosch, Floris T. M., Mulder, Frits I., Huisman, Menno V., Zwicker, Jeffrey I., Di Nisio, Marcello, Carrier, Marc, Segers, Annelise, Verhamme, Peter, Middeldorp, Saskia, Weitz, Jeffrey I., Grosso, Michael A., Duggal, Anil, Büller, Harry R., Wang, Tzu‐Fei, Garcia, David, Kamphuisen, Pieter Willem, Raskob, Gary E., van Es, Nick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
THROMBOSIS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292167/
https://www.ncbi.nlm.nih.gov/pubmed/34455706
http://dx.doi.org/10.1111/jth.15516

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292167/
https://www.ncbi.nlm.nih.gov/pubmed/34455706
http://dx.doi.org/10.1111/jth.15516

Ejemplares similares